Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Sign Up
Cited by 48

The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.

Chemotherapy-induced gut microbiome disruption, inflammation, and cognitive decline in female patients with breast cancer

Otto-Dobos, L.D., Grant, C.V., Lahoud, A.A., Wilcox, O.R., Strehle, L.D., Loman, B.R., Adarkwah Yiadom, S., Seng, M.M., Halloy, N.R., Russart, K.L.G., Carpenter, K.M., Dawson, E., Sardesai, S.D., Williams, N.O., Gatti-Mays, M.E., Stover, D.G., Sudheendra, P.K., Wesolowski, R., Kiecolt-Glaser, J.K., Bailey, M.T., Andridge, R.R., Pyter, L.M.·2024·Brain, Behavior, and Immunity
DOI 10.1016/j.bbi.2024.05.039
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.bbi.2024.05.039

Cites

8 of 8 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 8 references

Research works printed but not linked: 61

  1. Aarnoutse, 2022, Changes in intestinal microbiota in postmenopausal oestrogen receptor-positive breast cancer patients treated with (neo)adjuvant chemotherapy, NPJ Breast Cancer, 8, 89, 10.1038/s41523-022-00455-5 · DOI
  2. Al Bander, 2020, The Gut Microbiota and Inflammation: An Overview, Int J Environ Res Public Health, 17, 7618, 10.3390/ijerph17207618 · DOI · Paper page
  3. Benton, A.L., Hamsher, K., 1976. Multilingual aphasia examination (2nd ed.). AJA Associates.
  4. Bower, 2022, Acute and chronic effects of adjuvant therapy on inflammatory markers in breast cancer patients, JNCI Cancer Spectr, 6, 10.1093/jncics/pkac052 · DOI
  5. Castellon, 2004, Neurocognitive performance in breast cancer survivors exposed to adjuvant chemotherapy and tamoxifen, J Clin Exp Neuropsychol, 26, 955, 10.1080/13803390490510905 · DOI · Paper page
  6. Cerulla, 2017, Role of taxanes in chemotherapy-related cognitive impairment: A prospective longitudinal study, Breast Cancer Res Treat, 164, 179, 10.1007/s10549-017-4240-6 · doi:10.1007/s10549-017-4240-6
  7. Chen, 2012, Human intestinal lumen and mucosa-associated microbiota in patients with colorectal cancer, PLoS One, 7, e39743, 10.1371/journal.pone.0039743 · DOI · Paper page
  8. Deleemans, 2022, The chemo-gut pilot study: associations between gut microbiota, gastrointestinal symptoms, and psychosocial health outcomes in a cross-sectional sample of young adult cancer survivors, Current Oncology, 29, 2973, 10.3390/curroncol29050243 · DOI
  9. Dhillon, 2018, Perceived cognitive impairment in people with colorectal cancer who do and do not receive chemotherapy, Journal of Cancer Survivorship, 12, 178, 10.1007/s11764-017-0656-6 · DOI · Paper page
  10. Dranitsaris, 2005, Estimating the cost of illness in colorectal cancer patients who were hospitalized for severe chemotherapy-induced diarrhea, Canadian Journal of Gastroenterology, 19, 83, 10.1155/2005/618504 · DOI
  11. Edwardson, D.W., Parissenti, A.M., Kovala, A.T., 2019. Chemotherapy and Inflammatory Cytokine Signalling in Cancer Cells and theTumour Microenvironment. pp. 173–215. https://doi.org/10.1007/978-3-030-20301-6_9. · DOI
  12. Galloway-Peña, 2020, Gut microbiome signatures are predictive of infectious risk following induction therapy for acute myeloid leukemia, Clinical Infectious Diseases, 71, 63, 10.1093/cid/ciz777 · DOI · Paper page
  13. Grant, 2021, Manipulations of the gut microbiome alter chemotherapy-induced inflammation and behavioral side effects in female mice, Brain Behav Immun, 95, 401, 10.1016/j.bbi.2021.04.014 · DOI
  14. Gullett, 2019, Relationship of fatigue with cognitive performance in women with early-stage breast cancer over 2 years, Psychooncology, 28, 997, 10.1002/pon.5028 · DOI
  15. Hatayama, 2023, Characteristics of intestinal microbiota in japanese patients with mild cognitive impairment and a risk-estimating method for the disorder, Biomedicines, 11, 1789, 10.3390/biomedicines11071789 · DOI
  16. Henneghan, 2023, Validating the PROMIS cognitive function short form in cancer survivors, Breast Cancer Res Treat, 201, 139, 10.1007/s10549-023-06968-2 · DOI
  17. Hill, 2022, Facilitating a high-quality dietary pattern induces shared microbial responses linking diet quality, blood pressure, and microbial sterol metabolism in caregiver-child dyads, Gut Microbes, 14, 10.1080/19490976.2022.2150502 · DOI
  18. Hill, 2014, The international scientific association for probiotics and prebiotics consensus statement on the scope and appropriate use of the term probiotic, Nat Rev Gastroenterol Hepatol, 11, 506, 10.1038/nrgastro.2014.66 · DOI
  19. Jacobson, 1991, Clinical significance: A statistical approach to defining meaningful change in psychotherapy research, J Consult Clin Psychol, 59, 12, 10.1037/0022-006X.59.1.12 · DOI · Paper page
  20. Janelsins, 2018, Longitudinal trajectory and characterization of cancer-related cognitive impairment in a nationwide cohort study, Journal of Clinical Oncology, 36, 3231, 10.1200/JCO.2018.78.6624 · DOI · Paper page
  21. Janelsins, 2022, Relationships between cytokines and cognitive function from pre- to post-chemotherapy in patients with breast cancer, J Neuroimmunol, 362, 10.1016/j.jneuroim.2021.577769 · DOI · Paper page
  22. Johnson, 2012, Symptom validity indicators embedded in the controlled oral word association test, Clin Neuropsychol, 26, 1230, 10.1080/13854046.2012.709886 · DOI
  23. Jordan, 2018, Gut microbiota-immune-brain interactions in chemotherapy-associated behavioral comorbidities, Cancer, 124, 10.1002/cncr.31584 · DOI
  24. Juan, 2022, Probiotic supplement attenuates chemotherapy-related cognitive impairment in patients with breast cancer: a randomised, double-blind, and placebo-controlled trial, Eur J Cancer, 161, 10, 10.1016/j.ejca.2021.11.006 · DOI · Paper page
  25. Kim, 2022, Association of chemotherapy and subjective cognitive impairment in breast cancer patients: Meta-analysis of longitudinal prospective cohort studies, European Journal of Oncology Nursing, 57, 10.1016/j.ejon.2022.102099 · DOI
  26. Kong, 2019, Alterations in intestinal microbiota of colorectal cancer patients receiving radical surgery combined with adjuvant CapeOx therapy, Sci China Life Sci, 62, 1178, 10.1007/s11427-018-9456-x · DOI
  27. Koppelmans, 2012, Neuropsychological performance in survivors of breast cancer more than 20 years after adjuvant chemotherapy, Journal of Clinical Oncology, 30, 1080, 10.1200/JCO.2011.37.0189 · DOI · Paper page
  28. Levine, 2004, Normative data for determining significance of test-retest differences on eight common neuropsychological instruments, Clin Neuropsychol, 18, 373, 10.1080/1385404049052420 · DOI
  29. Liu, 2012, Fatigue and sleep quality are associated with changes in inflammatory markers in breast cancer patients undergoing chemotherapy, Brain Behav Immun, 26, 706, 10.1016/j.bbi.2012.02.001 · DOI · Paper page
  30. Loman, 2019, Chemotherapy-induced neuroinflammation is associated with disrupted colonic and bacterial homeostasis in female mice, Sci Rep, 9, 10.1038/s41598-019-52893-0 · DOI
  31. Lyon, 2016, Relationship of systemic cytokine concentrations to cognitive function over two years in women with early stage breast cancer, J Neuroimmunol, 301, 74, 10.1016/j.jneuroim.2016.11.002 · DOI
  32. Lyu, 2021, Kai-Xin-San Attenuates doxorubicin-induced cognitive impairment by reducing inflammation, oxidative stress, and neural degeneration in 4T1 breast cancer mice, Evid Based Complement Alternat Med, 2021, 10.1155/2021/5521739 · DOI
  33. Maajani, 2019, The global and regional survival rate of women with breast cancer: a systematic review and meta-analysis, Clin Breast Cancer, 19, 165, 10.1016/j.clbc.2019.01.006 · DOI · Paper page
  34. Maldonado, 2020, Estimation of US patients with cancer who may respond to cytotoxic chemotherapy, Future Sci OA, 6, 10.2144/fsoa-2020-0024 · DOI
  35. Matchado, 2024, On the limits of 16S rRNA gene-based metagenome prediction and functional profiling, Microb Genom, 10
  36. Montassier, 2015, Chemotherapy-driven dysbiosis in the intestinal microbiome, Aliment Pharmacol Ther, 42, 515, 10.1111/apt.13302 · DOI · Paper page
  37. Morton, 2019, Establishing microbial composition measurement standards with reference frames, Nat Commun, 10, 2719, 10.1038/s41467-019-10656-5 · DOI · Paper page
  38. Oh, 2021, Emerging evidence of the gut microbiome in chemotherapy: a clinical review, Front Oncol, 11, 10.3389/fonc.2021.706331 · DOI
  39. Okubo, 2020, Impact of chemotherapy on the association between fear of cancer recurrence and the gut microbiota in breast cancer survivors, Brain Behav Immun, 85, 186, 10.1016/j.bbi.2019.02.025 · DOI
  40. Panebianco, 2018, Pharmacomicrobiomics: exploiting the drug-microbiota interactions in anticancer therapies, Microbiome, 6, 92, 10.1186/s40168-018-0483-7 · DOI · Paper page
  41. Pusztai, 2004, Changes in plasma levels of inflammatory cytokines in response to paclitaxel chemotherapy, Cytokine, 25, 94, 10.1016/j.cyto.2003.10.004 · DOI · Paper page
  42. Rudzki, L., Maes, M., 2020. The Microbiota-Gut-Immune-Glia (MGIG) Axis in Major Depression. Molecular Neurobiology 2020 57:10 57, 4269–4295. https://doi.org/10.1007/S12035-020-01961-Y. · DOI
  43. Ruff, 1996, Benton controlled oral word association test: Reliability and updated norms, Archives of Clinical Neuropsychology, 11, 329, 10.1093/arclin/11.4.329 · doi:10.1093/arclin/11.4.329 · Paper page
  44. Shrode, 2023, Breast cancer patients from the Midwest region of the United States have reduced levels of short-chain fatty acid-producing gut bacteria, Sci Rep, 13, 526, 10.1038/s41598-023-27436-3 · DOI
  45. Singh, 2021, Technology meets tradition: a hybrid model for implementing digital tools in neuropsychology, International Review of Psychiatry, 33, 382, 10.1080/09540261.2020.1835839 · DOI
  46. Sougiannis, 2019, Impact of 5 fluorouracil chemotherapy on gut inflammation, functional parameters, and gut microbiota, Brain Behav Immun, 80, 44, 10.1016/j.bbi.2019.02.020 · DOI
  47. Subramaniam, 2020, The microbiota-gut-brain axis: An emerging therapeutic target in chemotherapy-induced cognitive impairment, Neurosci Biobehav Rev, 116, 470, 10.1016/j.neubiorev.2020.07.002 · DOI · Paper page
  48. Tombaugh, 2004, Trail Making Test A and B: Normative data stratified by age and education, Archives of Clinical Neuropsychology, 19, 203, 10.1016/S0887-6177(03)00039-8 · DOI · Paper page
  49. Tombaugh, 1999, Normative data stratified by age and education for two measures of verbal fluency: FAS and animal naming, Arch Clin Neuropsychol, 14, 167
  50. Vaccaro, 2023, Remote testing in Abbiategrasso (RTA): results from a counterbalanced cross-over study on direct-to-home neuropsychology with older adults, Aging Clin Exp Res, 35, 699, 10.1007/s40520-023-02343-9 · DOI
  51. van der Most, 2008, Decoding dangerous death: how cytotoxic chemotherapy invokes inflammation, immunity or nothing at all, Cell Death Differ, 15, 13, 10.1038/sj.cdd.4402255 · DOI
  52. Veal, 2023, Subjective cognition and memory lapses in the daily lives of breast cancer survivors: Examining associations with objective cognitive performance, fatigue, and depressed mood, Psychooncology, 32, 1298, 10.1002/pon.6185 · DOI
  53. Walker, 2023, Chemotherapy-induced weight gain in early-stage breast cancer: a prospective matched cohort study reveals associations with inflammation and gut dysbiosis, BMC Med, 21, 178, 10.1186/s12916-023-02751-8 · DOI
  54. Wefel, 2010, Acute and late onset cognitive dysfunction associated with chemotherapy in women with breast cancer, Cancer, 116, 3348, 10.1002/cncr.25098 · DOI · Paper page
  55. Wefel, 2011, Neurocognitive function in patients with recurrent glioblastoma treated with bevacizumab, Neuro Oncol, 13, 660, 10.1093/neuonc/nor024 · DOI
  56. Wefel, 2011, International Cognition and Cancer Task Force recommendations to harmonise studies of cognitive function in patients with cancer, Lancet Oncol, 12, 703, 10.1016/S1470-2045(10)70294-1 · DOI · Paper page
  57. Whittaker, 2022, Prevalence of cognitive impairment following chemotherapy treatment for breast cancer: a systematic review and meta-analysis, Sci Rep, 12, 2135, 10.1038/s41598-022-05682-1 · DOI · Paper page
  58. Yoo, 2020, Gut Microbiota and Immune System Interactions, Microorganisms, 8, 1587, 10.3390/microorganisms8101587 · DOI · Paper page
  59. Zhao, 2020, Changes in plasma IL-1β, TNF-α and IL-4 levels are involved in chemotherapy-related cognitive impairment in early-stage breast cancer patients, Am J Transl Res, 12, 3046
  60. Zhu, 2022, Altered Gut Microbiota and Its Clinical Relevance in Mild Cognitive Impairment and Alzheimer’s Disease: Shanghai Aging Study and Shanghai Memory Study, Nutrients, 14, 3959, 10.3390/nu14193959 · DOI
  61. Zidi, 2021, Fecal metabolic profiling of breast cancer patients during neoadjuvant chemotherapy reveals potential biomarkers, Molecules, 26, 10.3390/molecules26082266 · DOI

Metadata

Authors
Otto-Dobos, L. D., Grant, C. V., Lahoud, A. A., Wilcox, O. R., Strehle, L. D., Loman, B. R., Adarkwah Yiadom, S., Seng, M. M., Halloy, N. R., Russart, K. L. G., Carpenter, K. M., Dawson, E., Sardesai, S. D., Williams, N. O., Gatti-Mays, M. E., Stover, D. G., Sudheendra, P. K., Wesolowski, R., Kiecolt-Glaser, J. K., Bailey, M. T., Andridge, R. R., & Pyter, L. M.
Venue
Brain, Behavior, and Immunity
Publisher
Elsevier BV
Published
2024-08
Volume
120
Pages
208-220
ISSN
0889-1591
DOI
10.1016/j.bbi.2024.05.039
Cited by
48
References
8
Language
en
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Chemotherapy-induced gut microbiome disruption, inflammation, and cognitive decline in female patients with breast cancer. https://app.cochat.ai/papers/10.1016/j.bbi.2024.05.039
The paper
Otto-Dobos, L. D., Grant, C. V., Lahoud, A. A., Wilcox, O. R., Strehle, L. D., Loman, B. R., Adarkwah Yiadom, S., Seng, M. M., Halloy, N. R., Russart, K. L. G., Carpenter, K. M., Dawson, E., Sardesai, S. D., Williams, N. O., Gatti-Mays, M. E., Stover, D. G., Sudheendra, P. K., Wesolowski, R., Kiecolt-Glaser, J. K., . . . Pyter, L. M. (2024). Chemotherapy-induced gut microbiome disruption, inflammation, and cognitive decline in female patients with breast cancer. Brain, Behavior, and Immunity. https://doi.org/10.1016/j.bbi.2024.05.039

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.